Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group.
Borghetti P, Bonù ML, Giubbolini R, Levra NG, Mazzola R, Perna M, Visani L, Meacci F, Taraborrelli M, Triggiani L, Franceschini D, Greco C, Bruni A, Magrini SM, Scotti V. Borghetti P, et al. Among authors: visani l. Radiol Med. 2019 Jul;124(7):662-670. doi: 10.1007/s11547-019-00999-w. Epub 2019 Feb 15. Radiol Med. 2019. PMID: 30771218
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients.
Greto D, Loi M, Terziani F, Visani L, Garlatti P, Lo Russo M, Teriaca A, Muntoni C, Delli Paoli C, Topulli J, Campanacci D, Beltrami G, Scoccianti G, Bonomo P, Desideri I, Francolini G, Livi L. Greto D, et al. Among authors: visani l. Radiol Med. 2019 Apr;124(4):301-308. doi: 10.1007/s11547-018-0939-7. Epub 2018 Sep 12. Radiol Med. 2019. PMID: 30209796
Influence of age and subtype in outcome of operable liposarcoma.
Greto D, Saieva C, Loi M, Terziani F, Visani L, Garlatti P, Lo Russo M, Muntoni C, Becherini C, Topulli J, Campanacci D, Beltrami G, Scoccianti G, Muratori F, Bonomo P, Desideri I, Francolini G, Livi L. Greto D, et al. Among authors: visani l. Radiol Med. 2019 Apr;124(4):290-300. doi: 10.1007/s11547-018-0958-4. Epub 2018 Nov 12. Radiol Med. 2019. PMID: 30421387
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer.
Desideri I, Francolini G, Scotti V, Pezzulla D, Becherini C, Terziani F, Delli Paoli C, Olmetto E, Visani L, Meattini I, Greto D, Bonomo P, Loi M, Detti B, Livi L. Desideri I, et al. Among authors: visani l. Clin Transl Oncol. 2019 Jul;21(7):933-938. doi: 10.1007/s12094-018-02005-7. Epub 2018 Dec 18. Clin Transl Oncol. 2019. PMID: 30565084
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?
Bonomo P, Greto D, Desideri I, Loi M, Di Cataldo V, Orlandi E, Iacovelli NA, Becherini C, Visani L, Salvestrini V, Mariotti M, Livi L. Bonomo P, et al. Among authors: visani l. Oral Oncol. 2019 Jun;93:1-7. doi: 10.1016/j.oraloncology.2019.04.006. Epub 2019 Apr 8. Oral Oncol. 2019. PMID: 31109688
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience.
Francolini G, Campi R, Di Cataldo V, Detti B, Loi M, Triggiani L, La Mattina S, Borghetti P, Magrini SM, Nicosia L, Alongi F, Ghirardelli P, Vavassori V, Allegra AG, Aquilano M, Scoccimarro E, Peruzzi A, Pastina P, Visani L, Desideri I, Serni S, Meattini I, Livi L. Francolini G, et al. Among authors: visani l. Clin Transl Oncol. 2022 Oct;24(10):2039-2043. doi: 10.1007/s12094-022-02844-5. Epub 2022 Jun 23. Clin Transl Oncol. 2022. PMID: 35739349 Free PMC article.
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719).
Francolini G, Detti B, Di Cataldo V, Garlatti P, Aquilano M, Allegra A, Lucidi S, Cerbai C, Ciccone LP, Salvestrini V, Stocchi G, Guerrieri B, Visani L, Loi M, Desideri I, Mangoni M, Meattini I, Livi L. Francolini G, et al. Among authors: visani l. Radiol Med. 2022 Aug;127(8):912-918. doi: 10.1007/s11547-022-01511-7. Epub 2022 Jun 28. Radiol Med. 2022. PMID: 35763249 Free PMC article. Clinical Trial.
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort.
Francolini G, Carnevale MG, Di Cataldo V, Loi M, Detti B, Orsatti C, Caprara L, Bertini N, Lorenzetti V, Olmetto E, Becherini C, Visani L, Salvestrini V, Simontacchi G, Greto D, Bonomo P, Doro R, Masi L, Desideri I, Meattini I, Serni S, Livi L. Francolini G, et al. Among authors: visani l. Radiol Med. 2023 Dec;128(12):1580-1588. doi: 10.1007/s11547-023-01721-7. Epub 2023 Sep 20. Radiol Med. 2023. PMID: 37728816
Impact of fosaprepitant in the prevention of nausea and emesis in head and neck cancer patients undergoing cisplatin-based chemoradiation: a pilot prospective study and a review of literature.
Becherini C, Salvestrini V, Desideri I, Vagnoni G, Bonaparte I, Bertini N, Mattioli C, Angelini L, Visani L, Scotti V, Livi L, Caini S, Bonomo P. Becherini C, et al. Among authors: visani l. Radiol Med. 2024 Mar;129(3):457-466. doi: 10.1007/s11547-024-01757-3. Epub 2024 Feb 14. Radiol Med. 2024. PMID: 38351333 Free PMC article. Review.
58 results